• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Japanese regulators plan faster medical device registration process

Japanese regulators plan faster medical device registration process

March 31, 2014 By MassDevice Contributors Network

Japanese regulators plan faster medical device registration process

By Stewart Eisenhart, Emergo Group

A recent presentation by the Japanese Ministry of Health, Labour and Welfare’s Medical Device Evaluation office has shed more light on planned changes to the country’s medical device market regulatory system.

According to Emergo Group’s Tokyo office, the changes include both high-level amendments to Japan’s Pharmaceutical Affairs Law (PAL) applicable to both medical devices and drugs, and also measures specifically geared toward medical devices.

Proposed changes to medical device regulation in Japan include expanded third-party certification for some Class III devices, new regulatory requirements for certain stand-alone medical software, simplification of medical device licensing, and streamlined PAL quality management system requirements. The MHLW’s Pharmaceuticals and Medical Devices Agency (PMDA) is expected to begin enforcing these changes in November 2014.

PAL changes affecting medical devices

One goal of the PAL reform effort is to develop distinct regulations for medical devices as opposed to rules currently applied to both devices and pharmaceuticals. Among PAL amendments that will have a significant impact on medical device manufacturers are:

  • Expansion of private third-party certification to include some highly controlled Class III devices (Currently only certain Class  II devices are eligible for third-party certification)
  • Stand-alone regulatory requirements for software and programs used to process or store medical data
  • Shifting manufacturer licensing  and accrediting system for foreign manufacturing facilities to a registration system (In Japan, “manufacturer” means the entity doing manufacturing, not a legal manufacturer who is responsible for the market)
  • Elimination of prefect-level quality system inspection requirements
  • Streamlining quality system inspections to focus on units of product lines rather than individual 
  • New “Regenerative Product” category for products not easily classified as either drugs or devices

Accelerated device review plans

Sponsored by Emergo Group

In addition to PAL changes, the MHLW also plans to implement an accelerated approval process for medical devices, particularly those deemed highly necessary by the government for public health.

Over a four-year period, Japanese regulators will pursue quality improvements of PMDA application reviews via enhanced training of regulatory staff, more effective consultation with applicants and more standardized evaluations of applications.

By 2018, regulators also intend to set standard evaluation periods for all types of PMDA applications:

New medical device

Improved medical device

Generic medical device

Normal evaluation: 12 months

With clinical data: 9 months

New approval: 5 months

Priority evaluation: 9 months

Without clinical data: 7 months

Partial-change approval: 4 months

To meet these timeframes, the PMDA will shift gradually toward third-party rather than governmental certification for some Class III devices, as well as hold ongoing public-private consultations to evaluate whether measures to accelerate application reviews are working, or if additional steps should be adopted.

Bottom line: Manufacturers eager to commercialize in Japan must currently undergo a highly complex and lengthy medical device registration process.  Planned PAL amendments and PMDA medical device registration review changes should ease market entry pathways at least somewhat for many foreign manufacturers.

Stewart Eisenhart covers medical device regulatory affairs for Emergo Group.

Filed Under: News Well, Regulatory/Compliance Tagged With: Emergo Group, Japanese Ministry of Health

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy